Double Balloon Catheter Versus Dinoprostone Vaginal Insert for Cervical Ripening.
Launched by UNIVERSITÀ DEGLI STUDI DELL'INSUBRIA · Jul 26, 2010
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • singleton gestation
- • gestational age greater than 34 weeks
- • cephalic presentation
- • intact membranes
- • Bishop score of ≤4
- • reactive fetal heart rate (FHR) pattern on admission
- Exclusion Criteria:
- • any condition precluding vaginal delivery
- • any contraindication to receiving prostaglandins, including history of asthma, glaucoma, or cardiac or cardiovascular disease
- • previous cesarean section or other uterine incision
About Università Degli Studi Dell'insubria
The Università degli Studi dell'Insubria is a prestigious educational and research institution located in Italy, dedicated to advancing knowledge and innovation in various fields, including medicine and health sciences. With a strong commitment to academic excellence and interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving patient outcomes and contributing to the scientific community. Its robust research infrastructure and experienced faculty enable the development of cutting-edge studies that address critical healthcare challenges, ensuring that findings translate into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Varese, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials